Food and Drug Administration

FDA Approves 1st Non-Opioid Pain Medicine in 20 Years

FDA approves first new type of pain medication in 25 years

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill that’s taken every 12 hours after a larger starter dose.

The Associated Press on MSN · 7h

FDA approves painkiller designed to eliminate the risks of addiction associated with opioids

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

The Washington Post · 7h

FDA approves new, non-opioid painkiller Journavx

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.

FDA Sets Highest Risk Level For Over 6,000 Bags

al.com · 1d

Lay’s potato chip recall elevated to FDA’s highest-risk classification

The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause adverse health consequences. In December, Texas-based food manufacturer Frito Lay recalled a limited number of Lay’s Classic 13oz because the product could contain undeclared milk ingredients.

Newsweek on MSN · 1d

Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

USA TODAY on MSN · 1d

FDA upgrades Frito-Lay potato chips recall to highest risk level due to undeclared milk

Federal regulators have upgraded a product recall of Lay's Classic Potato Chips to the highest risk level for a batch that may contain undeclared milk ingredients. Last month, Frito-Lay issued a recall warning that more than 6,

type 2 diabetes, chronic kidney disease and FDA

CNN on MSN · 2d

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

Reuters · 2d

US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),

U.S. News & World Report · 1d

FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes

Doctors already use Ozempic to manage type 2 diabetes and reduce the risk of heart disease in patients with diabetes. This move, as reported by The Times, was based on research sh

FDA, migraine and Symbravo

Reuters · 10h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

Business Insider · 9h

Axsome Therapeutics announces FDA approval of Symbravo

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in

Investing.com on MSN · 8h

FDA approves new migraine treatment SYMBRAVO

NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue growth over the last twelve months, announced the U.S. Food and Drug Administration (FDA) has approved SYMBRAVO®,

11h

US FDA Identifies Cybersecurity Risks in Certain Patient Monitors

(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks ...

54mon MSN

Ketamine-derived nasal spray treating Phoenix patients with severe depression

A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The ...

10hOpinion

Do food warning labels actually work? Answering your questions.

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

2don MSN

Trump admin's FDA withdraws proposed federal rule to ban menthol cigarettes

Trump's FDA moved to squash a proposed rule to ban menthol cigarettes just one day after the president was sworn in, angering ...

58m

What really helps in the quest to maintain mental fitness?

All the experts say socializing, ideally while doing that intellectual activity, can help a lot, because it not only stimulates the brain, but keeps us from feeling lonely. Loneliness often leads to ...

1hon MSN

Intel's reliance on US funding is a symptom of its problems, says analyst

Ed Snyder of Charter Equity Research reacts to Intel's latest set of earnings, saying government help will not be enough to help turn the company's fortunes around.

Korea Joongang Daily on MSN44m

Celltrion's Actemra biosimilar gets FDA approval

Celltrion's biosimilar Avtozma, used to treat inflammatory diseases, was approved for the U.S. market by the Food and Drug Administration.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA Approves 1st Non-Opioid Pain Medicine in 20 Years

FDA Sets Highest Risk Level For Over 6,000 Bags

type 2 diabetes, chronic kidney disease and FDA

FDA, migraine and Symbravo

Related topics